RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
NCT03189914
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Pancreatic Cancer
Interventions
DRUG:
RX-3117
Sponsor
Processa Pharmaceuticals